Abstract:Abstract Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease characterized by recurring serosal inflammation. Cardiac involvement in FMF commonly manifests as pericarditis and pericardial effusion; however, there is limited research on myocardial function. This study aimed to assess cardiac functions during active inflammation and remission periods of FMF patients and investigate the cardiac effects of inflammation during the attack period. Thirty-eight FMF patients without additional cardiac diseases were included in the study. Demographic characteristics, clinical symptoms, family history, and MEFV gene analysis results were obtained retrospectively. Blood tests, blood pressure measurements, electrocardiogram evaluations, conventional echocardiography, and speckle tracking echocardiography were performed during the attack and remission periods. Disease severity was assessed using the Pras scoring system. During the attack period, FMF patients exhibited significantly higher leukocyte count, neutrophil count, C-reactive protein, and erythrocyte sedimentation rate compared to the remission period ( p < 0.005). Speckle tracking echocardiography revealed decreased function in the inferior segments of the left ventricle during the attack period ( p < 0.005). Right ventricular function was more affected in the moderate disease group. FMF patients with lymphopenia during the attack demonstrated more impaired right ventricular function compared to those with normal lymphocyte count. Conclusions : FMF patients experience cardiac abnormalities during active inflammation, highlighting the importance of monitoring cardiac functions in these patients. Speckle tracking echocardiography can provide valuable insights into cardiac involvement in FMF. These findings emphasize the cardiac impact of FMF inflammation and the significance of long-term cardiac function monitoring in the management of FMF patients. What is Known: • The current literature lacks studies investigating myocardial function in the pediatric population during the attack period of this particular disease. • Our objective was to assess the alterations in cardiac function during the attack and remission periods, considering clinical manifestations, disease severity, acute phase reactant levels, and mutation type. We also evaluated the pattern of cardiac involvement and the affected cardiac areas by comparing remission and attack periods . What is New: • Several studies have demonstrated a rise in the prevalence of ischemic cardiac disease and mortality among individuals with FMF. • Investigating cardiac involvement during the attack period in FMF patients can provide valuable insights for the prevention of long-term complications.

The assessment of fatigue and sleep quality among children and adolescents with familial Mediterranean fever: A case-control and correlation study

A preliminary study: relationship between inattention/hyperactivity and familial mediterranean fever in children and adolescents

Evaluation of cardiac functions in children with familial Mediterranean fever

Development of a medication adherence scale for familial Mediterranean fever (MASIF) in a cohort of Turkish children

Clinical significance of mean platelet volume, platelet distribution width, and neutrophil-lymphocyte ratio in children with familial mediterranean fever

Assessment of epicardial adipose tissue thickness and the mean platelet volume in children with familial Mediterranean fever

Comparison of Clinical and Genetic Characteristics of Familial Mediterranean Fever Patients Among Adult Age Groups

Altered expression of miR-17 and miR-148b in pediatric familial mediterranean fever patients

Genetic and Clinical Manifestations of Familial Mediterranean Fever in Children from the Central North of Iran

Examination of cardiac functions during acute attack and remission period in children with familial Mediterranean fever

The Prevalence of Familial Mediterranean Fever and Behçet's Disease: A Cross-Sectional Study

Protracted febrile myalgia syndrome in children with familial Mediterranean fever - systematic review and a case report

Molecular investigation of MEFV gene polymorphisms among patients with familial mediterranean fever-like symptoms

Genotypic Diagnosis of Familial Mediterranean Fever (FMF) Using New Microsatellite Markers: Example of Two Extensive Non-Ashkenazi Jewish Pedigrees.

PHYSICAL ACTIVITY LEVEL, SLEEP, FATIGUE AND QUALITY OF LIFE IN BEHÇET DISEASE AND FAMILIAL MEDITERRANEAN FEVER DISEASE DURING THE COVID 19 PANDEMIC

Retrospective evaluation of obstetric processes in patients with Familial Mediterranean Fever's disease: The three years experience of a tertiary rheumatology clinic

Prevalence and characteristics of juvenile fibromyalgia syndrome in pediatric rheumatic diseases: A comparative study

Phenotype-genotype correlation in children with familial Mediterranean fever in Morocco

Diagnostic delays in familial Mediterranean fever: a Juvenile Inflammatory Rheumatism (JIR) cohort study

Serum endocan, asymmetric dimethylarginine and lipid profile in children with familial Mediterranean fever

Ocular blood flow and retinal, choroidal, and retinal nerve fiber layer thickness in children with familial Mediterranean fever with at least five attacks